4-subsittution m sulfonylurea amide aniline-quinazoline derivate and preparation method and application thereof

A technology of quinazoline and derivatives, applied in the preparation of the 4-substituted m-methanesulfonamide anilino-quinazoline derivatives, the application field of anti-tumor drugs, can solve the problem of increasing the difficulty of curing and recurrence. probability, etc.

Inactive Publication Date: 2012-07-11
TIANJIN INSTITUTE OF PHARMA RESEARCH
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

If the receptors of cancer cells are overexpressed or overactivated, the cancer cells will gro

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 4-subsittution m sulfonylurea amide aniline-quinazoline derivate and preparation method and application thereof
  • 4-subsittution m sulfonylurea amide aniline-quinazoline derivate and preparation method and application thereof
  • 4-subsittution m sulfonylurea amide aniline-quinazoline derivate and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Example 1 Preparation of 2-benzyloxy-5-nitroaniline

[0026] Put 4g (25.97mmol) of 2-amino-4-nitrophenol, 4.9g (28.65mmol) of benzyl bromide, and 7.18g (52.02mmol) of potassium carbonate in a 100ml round bottom flask, add 30ml of acetone, and reflux at 60°C for 1.5 h, recrystallized from ethyl acetate to give 2-benzyloxy-5-nitroaniline (3.8g g, 58.8%) as a yellow solid, m.p.98-99°C; 1 H NMR (400MHz, DMSO): δ5.23(s, 2H, CH 2 O), 6.412 (s, 2H, NH 2 ), 6.6756.697 (d, 1H, ArH), 7.324-7.675 (m, 7H, ArH), ESI-MS: m / z 245 [M+H] + .

Embodiment 2

[0027] Example 2 Preparation of 1-(N-methylsulfonyl)-2-benzyloxy-5-nitroaniline

[0028] Put 1 g (4.10 mmol) of 2-benzyloxy-5-nitroaniline in a 100 ml round bottom flask, add 16 ml of DMF, and stir well. The system was placed in an ice bath, and 0.4 g of sodium hydrogen (16.67 mmol) was added in batches. Stir at room temperature for 30 min under nitrogen protection. Measure 1.42 g (12.40 mmol) of methanesulfonyl chloride, and slowly add it into the system. Stir overnight at room temperature. 30ml of water was added to the system, and a large amount of precipitation occurred. Filter and wash with water to obtain light yellow solid powder. It was dissolved in DMF, and the pH was adjusted to 9-10 with 3N aqueous sodium hydroxide solution. The reaction was carried out at 90° C. for 6 h, and then naturally cooled to room temperature. Adjust the pH to 1-2 with 5N hydrochloric acid, a large amount of precipitation appeared in the system, filtered and washed with water to obtain ...

Embodiment 3

[0029] Example 3 Preparation of N-(5-amino-2-(benzyloxy)phenyl)methanesulfonamide

[0030] 0.2 g (0.62 mmol) of 1-(N-methylsulfonyl)-2-benzyloxy-5-nitroaniline, FeCl 3 6H 2 O 0.67g (2.48mmol) was placed in a 50ml round bottom flask, and then 7ml of DMF and H 2 O (6:1), stirred at room temperature for 30 min. Weigh 0.4g Zn powder (6.13mmol), slowly add to the system, stir at room temperature for 3h, stop the reaction. Filter the reaction solution, take the filtrate, dilute it with 1-2 times the amount of water, then extract it with ethyl acetate, add HCl / ethyl acetate, a large amount of precipitation occurs, and filter it. Dissolve it in water, adjust the pH to alkaline, extract with ethyl acetate, and evaporate to dryness under reduced pressure to obtain N-(5-amino-2-(benzyloxy)phenyl)methanesulfonamide (0.16g, 92.3% ), m.p.103-104°C; 1 H NMR (400MHz DMSO): δ2.734(s, 3H, CH 3 ), 5.024 (s, 2H, NH 2 ), 5.154 (s, 2H, CH 2O), 6.094-7.524 (m, 8H, ArH), 8.46 (s, 1H, NH), ESI...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of pharmaceutical chemistry, and relates to a quinazoline derivate with a general formula (I) as well as the preparation method and the application thereof, wherein both R1 and R2 have meanings defined in an instruction. The invention also relates to the preparation method of the derivative. The derivative and inorganic and organic acid or alkali form salt which is acceptable physiologically, and drug combinations containing the derivative. The compound has valuable pharmacological properties and especially plays a role in restraining signal transduction aroused by tyrosine kinase; and particularly, a mutant EGFR (Epidermal Growth Factor Receptor) (L858R/T790M) and HER 2 have higher inhibitory activity. The invention also relates to a method for treating diseases, in particular to diseases characterized in abnormal erbB PTK (protein tyrosine kinase) activity. The general formula (I) is as follows.

Description

technical field [0001] The present invention relates to 4-substituted m-methylsulfonamidoanilino-quinazoline derivatives or pharmaceutically acceptable salts thereof, and these compounds have antitumor activity. The present invention also relates to a method for preparing said 4-substituted m-methylsulfonamidoanilino-quinazoline derivatives, a pharmaceutical composition containing these derivatives and their application in antineoplastic drugs. Background technique [0002] Tyrosine Kinase Inhibitor mainly acts on epidermal growth factor receptor (EGFR). EGFR has an important influence and control correlation on the growth of cancer cells. If the receptors of cancer cells are overexpressed or overactivated, the cancer cells will grow in large numbers, thereby increasing the difficulty of curing and the probability of recurrence. EGFR receptors can be divided into four types of human epidermal growth factor receptors (Human Epidermal Receptor). The first type is usually ca...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D405/04C07D405/06A61K31/517A61K31/5377A61P35/00
Inventor 李祎亮蔡志强刘巍石玉邹美香张士俊商倩孟凡翠徐为人李洪明刘经国纪潇朗商骐鸣
Owner TIANJIN INSTITUTE OF PHARMA RESEARCH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap